Anna Scattone

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell-of-Origin Assignment of Diffuse Large B-Cell Lymphoma.

A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell-of-Origin Assignment of Diffuse Large B-Cell Lymphoma.

Journal: European journal of haematology

Published: May 19, 2026

Predicting modelling for early diagnosis in early myeloproliferative neoplasms, not otherwise specified. Evidence from a machine learning study.

Predicting modelling for early diagnosis in early myeloproliferative neoplasms, not otherwise specified. Evidence from a machine learning study.

Journal: Frontiers in oncology

Published: November 07, 2025

High-Throughput Molecular Characterization of the Microbiome in Breast Implant-Associated Anaplastic Large Cell Lymphoma and Peri-Implant Benign Seromas.

High-Throughput Molecular Characterization of the Microbiome in Breast Implant-Associated Anaplastic Large Cell Lymphoma and Peri-Implant Benign Seromas.

Journal: Cancers

Published: October 23, 2025

Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodology.

Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodology.

Journal: Frontiers in oncology

Published: May 12, 2025

A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes.

A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes.

Journal: Haematologica

Published: February 22, 2024

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.

Journal: Hematological oncology

Published: May 05, 2022

Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology.

Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology.

Journal: Scientific reports

Published: July 01, 2021

The role of rapid on site evaluation on touch imprint cytology and brushing during conventional bronchoscopy.

The role of rapid on site evaluation on touch imprint cytology and brushing during conventional bronchoscopy.

Journal: Diagnostic cytopathology

Published: February 08, 2021

Early indicators in anaplastic large-cell periprosthetic lymphoma of the breast: clarifications.

Early indicators in anaplastic large-cell periprosthetic lymphoma of the breast: clarifications.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: October 25, 2020

Diagnostic challenges and potential early indicators of breast periprosthetic anaplastic large cell lymphoma: A case report.

Diagnostic challenges and potential early indicators of breast periprosthetic anaplastic large cell lymphoma: A case report.

Journal: Medicine

Published: August 15, 2020

Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study.

Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study.

Journal: Diagnostics (Basel, Switzerland)

Published: May 12, 2020

Pharmacotherapy in Mast Cell Leukemia.

Pharmacotherapy in Mast Cell Leukemia.

Journal: Expert opinion on pharmacotherapy

Published: March 27, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026